$ Value
$15K
Shares
488
Price
$32
Filed
Mar 31
Insider
Name
Huang Michael F.
Title
Sr. VP of Clinical Development
CIK
0002019992
Roles
Transaction Details
Transaction Date
2026-03-27
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
39,823
Footnotes
These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). | This transaction was executed in multiple trades at prices ranging from $29.54 to $30.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. | This transaction was executed in multiple trades at prices ranging from $30.545 to $31.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | This transaction was executed in multiple trades at prices ranging from $31.64 to $31.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Filing Info
Huang Michael F.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-27 | SLNO | ▼ | $128K |
| 2026-03-27 | SLNO | ▼ | $57K |
| 2026-03-27 | SLNO | ▼ | $15K |
Other Insiders at SLNO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Manning Meredith
Chief Commercial Officer
|
— | $229K | 2026-03-27 |
|
Huang Michael F.
Sr. VP of Clinical Development
|
— | $185K | 2026-03-27 |